I begge undersøgelser var patienterne randomiseret til at få enten placebo, 5 mg/ kg Remicade eller 10 mg/ kg Remicade i uge 0, 2, 6, 14 og 22, og i ACT 1 i uge 30, 38 og 46.
In both studies, patients were randomized to receive either placebo, 5 mg/ kg Remicade, or 10 mg/ kg Remicade at weeks 0, 2, 6, 14 and 22, and in ACT 1 at weeks 30, 38 and 46.